We are live on ! Find out more

3,013 hedge funds and large institutions have $171B invested in Merck in 2022 Q2 according to their latest regulatory filings, with 182 funds opening new positions, 1,352 increasing their positions, 1,132 reducing their positions, and 82 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more first-time investments, than exits

New positions opened: 182 | Existing positions closed: 82

120% more funds holding in top 10

Funds holding in top 10: 108238 (+130)

27% more call options, than puts

Call options by funds: $2.56B | Put options by funds: $2.02B

19% more repeat investments, than reductions

Existing positions increased: 1,352 | Existing positions reduced: 1,132

13% more capital invested

Capital invested by funds: $151B → $171B (+$19.6B)

2% more funds holding

Funds holding: 2,9523,013 (+61)

0.99% more ownership

Funds ownership: 73.3%74.29% (+0.99%)

Holders
3,013
Holders Change
+61
Holders Change %
+2.07%
% of All Funds
50.76%
Holding in Top 10
238
Holding in Top 10 Change
+130
Holding in Top 10 Change %
+120.37%
% of All Funds
4.01%
New
182
Increased
1,352
Reduced
1,132
Closed
82
Calls
$2.56B
Puts
$2.02B
Net Calls
+$541M
Net Calls Change
-$193M
Name Holding Trade Value Shares
Change
Change in
Stake
LFA
2151
Landmark Financial Advisors
Kentucky
$654K -$46.8K -528 -7%
PWS
2152
Peterson Wealth Services
Utah
$654K +$91.8K +1,036 +17%
CA
2153
Crumly & Associates
Illinois
$653K -$66.2K -747 -9%
LAM
2154
Lynch Asset Management
Pennsylvania
$653K
HCM
2155
Highview Capital Management
Illinois
$652K -$37.5K -423 -6%
ECG
2156
Edge Capital Group
Georgia
$651K -$7.24M -81,722 -95%
DU
2157
Delphia (USA)
Ontario, Canada
$651K +$633K +7,142 New
PTB
2158
Pioneer Trust Bank
Oregon
$650K -$169K -1,910 -21%
Pzena Investment Management
2159
Pzena Investment Management
New York
$650K +$181K +2,043 +40%
SP
2160
Successful Portfolios
Florida
$649K -$4.43K -50 -0.7%
CSI
2161
Cross Staff Investments
New York
$646K
CCA
2162
Cottonwood Capital Advisors
Utah
$645K -$4.43K -50 -0.7%
GIM
2163
Groesbeck Investment Management
New Jersey
$642K -$19.1K -216 -3%
SFS
2164
Summit Financial Strategies
Ohio
$641K +$75.4K +850 +14%
VBCG
2165
Valley Brook Capital Group
Pennsylvania
$639K -$26.6K -300 -4%
PCM
2166
Pointe Capital Management
Michigan
$638K
CPSC
2167
Carl P. Sherr & Co
Massachusetts
$638K +$129K +1,452 +26%
GA
2168
Geller Advisors
New York
$634K -$266 -3 -0%
GCP
2169
GSA Capital Partners
United Kingdom
$633K -$424K -4,780 -41%
MA
2170
MONECO Advisors
Connecticut
$633K +$36.3K +409 +6%
MA
2171
MJP Associates
Connecticut
$632K +$150K +1,695 +32%
SB
2172
Strategic Blueprint
Georgia
$630K +$97.1K +1,095 +19%
WA
2173
Waddell & Associates
Tennessee
$629K +$2.39K +27 +0.4%
FWM
2174
Focused Wealth Management
New York
$624K -$4.7K -53 -0.8%
CC
2175
Cornerstone Capital
California
$624K

MRK Hedge Fund Activity: Q2 2022 in Review

3,013 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q2 2022, worth a combined $171B — up 13% from $151B a quarter earlier.

Buyers outnumbered sellers: 182 funds opened new MRK positions and 82 closed out — a net gain of 100 holders — while 1,352 added to existing stakes and 1,132 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $1.11B. The largest seller was Franklin Resources, cutting an estimated $596M.

  • 3,013 institutional investors held Merck (MRK) as of Q2 2022, up from 2,952 in Q1 2022.
  • Funds reported $171B of Merck stock for Q2 2022, up 13% quarter-over-quarter.
  • 182 funds opened new Merck positions in Q2 2022 and 82 closed out, a net change of +100 holders.
  • The largest Merck buyer in Q2 2022 was Morgan Stanley, an estimated $1.11B added.
  • The largest Merck seller in Q2 2022 was Franklin Resources, an estimated $596M sold.

Based on aggregated 13F filings for Q2 2022.